Ireland
--:--IST
Latest
Clinical Trials in France / NCT07384819
Starting soon Not applicable

Duration of Moment in Autism

NCT07384819 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-02-16
Last updated
2026-02-05

Condition(s) studied

Autism Spectrum Disorder

Investigational drug(s) / intervention(s)

Temporal Integration Window taskAttentional Blink task

Temporal Integration Window task: The TIW task involves alternating visual displays (integration and segmentation trials) across four inter-stimulus intervals (ISI: 16, 32, 83, 116 ms). This task allows estimation of the participant's perceptual integration threshold.

Attentional Blink task: The Attentional Blink task presents rapid sequences of images (including two targets and distractors), measuring the minimum time delay required for both targets to be detected. Three different T1-T2 intervals are tested.

Study summary

This study investigates the temporal dynamics of perception and attention in children with Autism Spectrum Disorder (ASD), focusing on two key phenomena: the Temporal Integration Window (TIW) and the attentional blink. Using eye-tracking, 3- and 5-year-old children with ASD (prototypical or not) will be compared to age-matched neurotypical peers.

The investigators hypothesize that children with ASD exhibit shorter TIWs and attentional blinks, reflecting faster perceptual sampling and attentional processing. These characteristics may contribute to sensory hypersensitivity and difficulties in complex, unpredictable environments such as social situations. The protocol includes two experimental tasks.

Eligibility

Sex
ALL
Min age
36 Months
Max age
71 Months
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 3 or 5 years * Either with a diagnosis of Autism Spectrum Disorder (ASD) or typically developing (neurotypical) * No intellectual disability (per Mullen, Denver, or psychometric report) * Normal or corrected vision and hearing * Written informed consent from legal guardians * Legal guardians affiliated to a French social security plan * For ASD group only : classification as prototypical or non-prototypical based on clinical evaluation Exclusion Criteria: * Neurological disorder * Parental or child refusal to participate * For neurotypical children: developmental delay or psychiatric diagnosis

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Baby lab - Institut des sciences cognitives Marc Jeannerod Bron France
CEDA - Le Vinatier Bron France

More Hôpital le Vinatier trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07384819 on ClinicalTrials.gov ↗ ← All trials in France